currently left femoral nerve neuropathy.; diagnosis: initial left lower limb paraesthesia, subsequent left hemisoma paraesthesia; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. regulatory number: it-minisal02-842862. a 27 year-old female patient received bnt162b2 (comirnaty), intramuscular, administered in arm left, administration date 27jul2021 (lot number: ff2752) at the age of 27 years as dose 2, single for covid-19 immunisation. relevant medical history included: "polycystic ovary syndrome" (unspecified if ongoing); "cypress pollen allergy" (unspecified if ongoing). the patient's concomitant medications were not reported. past drug history included: amoxicillin-clavulanic acid, reactions: "presumed allergy". vaccination history included: covid-19 vaccine (1st dose, manufacturer unknown), for covid-19 immunization. the following information was reported: neuropathy peripheral (hospitalization) with onset 27jul2021, outcome "not recovered", described as "currently left femoral nerve neuropathy."; paraesthesia (hospitalization) with onset 27jul2021, outcome "not recovered", described as "diagnosis: initial left lower limb paraesthesia, subsequent left hemisoma paraesthesia". actions taken: private visits to a neurologist, analysis and assessment tests, drug therapy. impact on quality of life (10/10) no follow-up attempts are possible. no further information is expected